Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shanghai Zhongshan Hospital | OTHER |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | OTHER |
| Guangdong Provincial People's Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
TruePhysioTM Sensor-equipped Ultrathin Pressure Microcatheter (referred to as TruePhysioTM Microcatheter below) is a novel device for evaluating the functional significance of coronary stenosis. This study will compare the differences, if any, between the coronary fractional flow reserve (FFR) measured by the TruePhysioTM Microcatheter and the Pressure Wire.
Many studies have reported that FFR-guided coronary revascularization leads to improved long-term clinical outcomes and reduced costs compared with angiography-guided coronary revascularization alone. Current guidelines emphasize the measurement of FFR as the standard of reference when determining the functional significance of coronary artery stenosis in stable patients when evidence of ischemia is not available (class IA indication). But FFR is still underutilized in clinical practice. One of the reasons may be the difficulty in manipulating the Pressure Wire.
TruePhysioTM Microcatheter is a novel device for evaluating the functional significance of coronary stenosis, which may simplify FFR measurements by allowing the use of standard guidewires best suited to negotiating the patients' anatomy. This study is a prospective, open label, multi-center study with the purpose of comparing the differences, if any, between FFR measured by the TruePhysioTM Microcatheter and Pressure Wire. The secondary purpose is to analyze the correlation between FFR measured by the TruePhysioTM Microcatheter and Pressure Wire. A total of 239 patients will be recruited at 4 centers in China.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participants | Subjects who meet the inclusion criteria and do not meet the exclusion criteria and undergo FFR measurement with the TruePhysioTM Microcatheter and the Pressure Wire |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TruePhysioTM Microcatheter | Device | Provide hemodynamic information for the diagnosis and treatment of coronary and peripheral artery disease. The system is intended for use in catheterization and related cardiovascular specialty laboratories to compute and display fractional flow reserve (FFR). |
| Measure | Description | Time Frame |
|---|---|---|
| FFR Measurements | Comparisons between the FFR measured by the TruePhysioTM Microcatheter and the Pressure Wire (PW), including bias, as assessed by Bland-Altman analysis. | Duration of FFR measurement |
| Measure | Description | Time Frame |
|---|---|---|
| Pearson analysis | Pearson analysis of paired FFR measurements by TruePhysioTM Microcatheter and PW. | Duration of FFR measurement |
| Slope of Passing-Bablok fit | Slope of Passing-Bablok fit between paired FFR measurements by TruePhysioTM Microcatheter and PW. |
Not provided
General Inclusion Criteria:
Angiographic Inclusion Criteria:
Exclusion Criteria:
General Exclusion Criteria:
Angiographic Exclusion Criteria:
Not provided
Not provided
Patients with coronary artery disease for whom FFR measurement is thought to be clinically indicated.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Guangdong General Hospital | Guangzhou | China | ||||
| Second Affiliated Hospital, School of Medicine, Zhejiang University |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33951285 | Result | Li C, Yang J, Dong S, Dong L, Chen J, Shen L, Zhang F, Li C, Liu H, Hu X, Hau WK, Qian J, Jeremias A, Wang J, Ge J; SUPREME Study Investigators. Multicenter clinical evaluation of a piezoresistive-MEMS-sensor rapid-exchange pressure microcatheter system for fractional flow reserve measurement. Catheter Cardiovasc Interv. 2021 Aug 1;98(2):E243-E253. doi: 10.1002/ccd.29678. Epub 2021 May 5. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
Not provided
Not provided
| Shenzhen People's Hospital |
| OTHER |
Not provided
Not provided
Not provided
|
|
| Pressure Wire | Device | Provide hemodynamic information for the diagnosis and treatment of coronary and peripheral artery disease. The system is intended for use in catheterization and related cardiovascular specialty laboratories to compute and display fractional flow reserve (FFR). |
|
|
| Duration of FFR measurement |
| Intercept of Passing-Bablok fit | Intercept of Passing-Bablok fit between paired FFR measurements by TruePhysioTM Microcatheter and PW. | Duration of FFR measurement |
| Diagnostic FFR concurrence of functionally significant stenosis | Concurrence of TruePhysioTM Microcatheter FFR diagnostic accuracy of functionally significant stenosis, using PW FFR ≤0.80 as the reference. | Duration of FFR measurement |
| Sensitivity, Specificity of TruePhysioTM Microcatheter in determining functionally significant stenosis | Sensitivity, Specificity of TruePhysioTM Microcatheter in determining functionally significant stenosis at the vessel level with PW FFR as the reference standard (PW FFR ≤0.80 as positive case). | Duration of FFR measurement |
| Device success rate | Device success rate, defined as a valid FFR reading for each system, and comparison between the two systems. | Duration of FFR measurement |
| Mean drift | Mean drift, defined as the absolute difference between Pd/Pa at the equalization position after pullback and 1.00, for each system, and comparison between the two systems. | Duration of FFR measurement |
| Rate of clinically significant drift | Rate of clinically significant drift (drift >0.03), for each system, and comparison between the two systems. | Duration of FFR measurement |
| Rate of device-related adverse effects | Rate of device-related adverse effects, for each system individually, and comparison between the two systems. | Duration of FFR Procedure |
| PW FFR measurements with TruePhysioTM Microcatheter across and not across lesion | Comparisons between PW FFR measurements with TruePhysioTM Microcatheter across lesion and with TruePhysioTM Microcatheter not across lesion, including bias, as assessed by Bland-Altman analysis. | Duration of FFR Procedure |
| Hangzhou |
| China |
| Shanghai Zhongshan Hospital | Shanghai | China |
| Shenzhen People's Hospital | Shenzhen | China |
| D014652 |
| Vascular Diseases |